亚洲心房颤动研究进展：迟做总比不做好。 - Suppr

Suppr

超能文献

Atrial Fibrillation Advances in Asia: Better Late Than Never.

作者信息

Serebruany Victor, Hwang Isabella, Cabrera-Fuentes Hector A

机构信息

Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.

HeartDrug Research LLC, West Friendship, Maryland, USA.

出版信息

JACC Asia. 2025 Jan 21;5(1):203-204. doi: 10.1016/j.jacasi.2024.11.007. eCollection 2025 Jan.

DOI:10.1016/j.jacasi.2024.11.007

PMID:39896251

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782001/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff9a/11782001/7fa6dbc6a29e/ga1.jpg

相似文献

Atrial Fibrillation Advances in Asia: Better Late Than Never.亚洲心房颤动研究进展：迟做总比不做好。

JACC Asia. 2025 Jan 21;5(1):203-204. doi: 10.1016/j.jacasi.2024.11.007. eCollection 2025 Jan.

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.种族/民族与心房颤动患者口服抗凝药物使用的相关性：来自更好地了解心房颤动治疗的结果登记 II 研究的结果。

JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.

Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.新发心房颤动合并慢性肾脏病患者的管理及 1 年转归：前瞻性 GARFIELD-AF 登记研究结果。

J Am Heart Assoc. 2019 Feb 5;8(3):e010510. doi: 10.1161/JAHA.118.010510.

Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.口服抗凝药可改善高龄中国房颤患者的生存状况：来自优化老年房颤患者抗栓治疗中国注册研究（ChiOTEAF）的报告。

Int J Stroke. 2022 Jul;17(6):661-668. doi: 10.1177/17474930211046743. Epub 2021 Sep 22.

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).心房颤动患者抗凝治疗中断期间桥接治疗的使用情况及相关结局：心房颤动更明智治疗结局登记研究（ORBIT-AF）的结果

Circulation. 2015 Feb 3;131(5):488-94. doi: 10.1161/CIRCULATIONAHA.114.011777. Epub 2014 Dec 12.

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.在心房颤动患者中同时使用阿司匹林治疗和口服抗凝治疗的情况及相关风险：来自 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation（ORBIT-AF）登记研究的见解。

Circulation. 2013 Aug 13;128(7):721-8. doi: 10.1161/CIRCULATIONAHA.113.002927. Epub 2013 Jul 16.

[Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy - REGATTA)].

Ter Arkh. 2021 Sep 15;93(9):1037-1043. doi: 10.26442/00403660.2021.09.201019.

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).在临床实践中，非维生素K拮抗剂口服抗凝剂与华法林治疗心房颤动患者大出血的管理比较（来自心房颤动更明智治疗结果登记处[ORBIT-AF II]的第二阶段）

Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28.

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.医疗补助计划覆盖的房颤患者的临床特征、口服抗凝模式及转归：来自房颤更明智治疗转归登记研究（ORBIT-AF I）登记处的见解

J Am Heart Assoc. 2016 May 4;5(5):e002721. doi: 10.1161/JAHA.115.002721.

Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study.用于房颤卒中预防的达比加群与维生素 K 拮抗剂的患者感知和治疗便利性：长期抗凝治疗经验真实世界评估（RE-LATE）研究。

Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001745.

本文引用的文献

Atrial fibrillation: stroke prevention.心房颤动：预防中风。

Lancet Reg Health Eur. 2024 Feb 1;37:100797. doi: 10.1016/j.lanepe.2023.100797. eCollection 2024 Feb.

Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations.东亚人群急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗栓治疗

JACC Asia. 2022 Feb 15;2(1):1-18. doi: 10.1016/j.jacasi.2021.12.005. eCollection 2022 Feb.

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry.根据抗血栓策略的房颤临床结局发生率：COOL-AF 登记研究。

Cardiovasc Ther. 2022 Feb 21;2022:5797257. doi: 10.1155/2022/5797257. eCollection 2022.

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry.全国登记处中心房颤动的死亡风险及时间模式

J Arrhythm. 2021 Oct 6;37(6):1434-1442. doi: 10.1002/joa3.12643. eCollection 2021 Dec.

Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study.泰国基于社区的新型筛查中房颤的患病率和风险概况：一项前瞻性多中心研究。

Int J Cardiol Heart Vasc. 2021 Jan 12;32:100709. doi: 10.1016/j.ijcha.2020.100709. eCollection 2021 Feb.

Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand.华法林护理包与新型口服抗凝剂在泰国预防房颤患者卒中的成本效益比较。

Thromb Res. 2020 Jan;185:63-71. doi: 10.1016/j.thromres.2019.11.012. Epub 2019 Nov 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验